Presently, we investigate ways to increase the bystander cytotoxicity of cytochrome P450-based GDEPT [8,22] by inhibiting the caspase 9-dependent apoptotic death [33] that occurs in tumor cells infected with adenovirus expressing the CPA-activating P450 enzyme CYP2B6. Here, CASP9 is linked to neoplasm.